Our monthly report on AI, ML, DL, and NLP in healthcare looks at who, what, where, and how the use of artificial intelligence is changing healthcare for the better. We will bring you some of the latest news and product information along with thought leader posts and our AI playlist of episodes from Healthcare NOW Radio.
In the News
DirectTrust® Launches Artificial Intelligence Accreditation Program; Two Organizations Achieve Accreditation Following Beta Participation
DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, launched its Artificial Intelligence (AI) v1.0 Accreditation Program and recognized D.A.W. Systems and ZeOmega as the first organizations to achieve Foundational accreditation, and Inpriva as a Candidate for Comprehensive accreditation, following participation in the program’s beta process. The final criteria are now publicly available, establishing structured requirements for organizations developing or deploying AI in healthcare, with an emphasis on governance, transparency, risk management, performance evaluation, and ongoing oversight.
Netsmart Collaborates with AWS, Using Kiro to Advance AI-Enabled Healthcare Technology
Netsmart, an industry-leading developer of electronic health records (EHRs), augmented intelligence and automation technologies for human services and post-acute providers, announced internal engineering results from its strategic collaboration with Amazon Web Services (AWS). Through the adoption of Amazon Kiro, an agentic AI-powered development tool from AWS, Netsmart realized significant gains in strengthening efficient innovation across engineering workflows and accelerated software delivery across its organization for healthcare provider clients.
Linus Health Digital Cognitive Assessments Meet or Surpass New CEOi Benchmarks for Early Cognitive Impairment Detection
Linus Health, an AI-driven brain health company focused on early detection and proactive intervention, announced that its digital solutions meet or exceed the performance criteria suggested in recent recommendations from the Global CEO Initiative on Alzheimer’s Disease (CEOi) for clinic-based digital cognitive assessments.
Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
Reimagine Care announced the expansion of its AI-enabled virtual oncology care program with Moffitt Cancer Center, building on early outcomes during an initial implementation phase related to patient engagement, symptom management, and acute care utilization. The model extends cancer care beyond scheduled visits through continuous support powered by Reimagine Care’s AI-powered assistant, Remi, and a dedicated oncology virtual care team.
Wolters Kluwer Releases Validation Framework for Evaluating Clinical AI at Point of Care
Wolters Kluwer Health released its approach to validating and evaluating clinical AI that is designed to reflect how clinicians use and rely on AI at the point of care. Designed to help support governance committees, this framework moves beyond basic output evaluation to assess whether AI-generated outputs are clinically useful, grounded in trusted knowledge, and reliable to use in complex, real-world point of care scenarios.
Briya Partners with InterSystems to Launch AI-Powered Conversation Research Capabilities Across Global Markets
Briya, the health AI technology company redefining healthcare research, announced a strategic partnership with InterSystems, a creative data technology provider powering more than one billion health records globally. The collaboration integrates Briya’s end-to-end AI research platform with InterSystems’ data connectivity, allowing healthcare and life sciences organizations to translate massive volumes of raw data into the evidence needed to advance discovery and patient care.
Federation of State Medical Boards Announces New Workgroup on Regulation of Artificial Intelligence in Medical Practice
The Federation of State Medical Boards (FSMB) announced the formation of an FSMB Workgroup on the Regulation of Artificial Intelligence in the Practice of Medicine, a new initiative aimed at supporting state medical boards as they navigate the rapid integration of artificial intelligence (AI) into patient care and the growing range of regulatory sandbox frameworks being proposed and implemented across the country.
Ascendo AI Independently Recognized by Gartner for Prescriptive Maintenance Architecture
Ascendo AI announced that it has been independently included by Gartner analysts as a Representative Provider in the research report “How CIOs Should Use AI to Enable Prescriptive Maintenance.” The research highlights the growing importance of prescriptive maintenance and AI‑driven, context‑aware guidance to help asset‑intensive organizations move from fault detection to action in the field.
Products
Varist Announces AI-Scale Malware Detection for Healthcare and Medical Imaging
Varist introduced its DICOM Detection Engine™, a specialized system designed to safeguard healthcare communications networks, electronic health records (EHR) and picture archiving and communication systems (PACS) used in medical imaging from malware, including AI-powered malware that employs artificial intelligence to automate, scale and customize cyberattacks. The Varist malware detection engine combines large-scale file scanning with real-time simulation of suspicious files to quickly detect and analyze emerging threats within milliseconds.
Caregility Collaborates with Microsoft to Bring Hands-Free, Real-Time AI Documentation to the Patient Bedside for Nurses
Caregility, a global provider of AI-enabled enterprise connected care, announced its Caregility Connected Care Platform will be integrated with Microsoft Dragon Copilot. Dragon Copilot, an AI clinical assistant, is the latest integration available to clinical teams through the Caregility platform, which leverages sensor-based technology in the patient room to help improve clinical communication, collaboration, engagement, and outcomes.
QuantHealth Launches Predictive Competitive Positioning Capabilities to Help Life Sciences Companies Optimize for Market Success
QuantHealth, the category leader in AI-driven clinical trial simulation, announced the launch of its predictive competitive intelligence solution, an unprecedented capability designed to help life sciences organizations optimize not only for clinical trial success, but for future market leadership.
ConcertAI Expands CancerLinQ Suite with AI-Driven Trial Matching and Contextualized Patient Insights to Support Oncologists at the Point of Care
ConcertAI®, the real world healthcare intelligence company for those advancing research, treatment, and care in oncology and other complex diseases, is unveiling enhancements to its CancerLinQ® Suite at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The new capabilities leverage clinically intelligent AI to parse through large volumes of structured and unstructured data on a weekly basis, giving oncologists and clinical care teams faster, more contextualized intelligence to support clinical trial matching and treatment decisions, all within their existing workflow.
Wolters Kluwer Adds Expert AI Features to CoursePoint+ to Support Nurse Faculty
Wolters Kluwer Health announced the launch of Lippincott® CoursePoint+ Faculty Assistant, powered by Expert AI, and the expansion of Nursing Tutor Usage Insights. Nurse educators can save time and reduce administrative burdens by using Faculty Assistant to quickly generate teaching materials such as case studies, learning activities, and quiz questions that are evidence-based and aligned with their curricula. Nursing Tutor Usage Insights helps educators track students’ AI query trends in the Expert AI-powered Nursing Tutor.
To Read
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine, announced publication of successful multi-site validation of its software, which received U.S. Food and Drug Administration clearance in 2024 for predicting the one-year risk of atrial fibrillation or flutter (AF). The study, titled “Multi-Center Validation of an Artificial Intelligence-Enabled ECG Model to Predict 1-Year Risk of Atrial Fibrillation or Flutter,” was recently published in Heart Rhythm.
Upcoming Events
AI Leadership Summit Boston – HIMSS Event
When: June 24, 2026
Where: Renaissance Boston Seaport District, Boston MA
Event Page
Register for this event.
The AI Leadership Summit is an exclusive, one-day gathering designed for senior executives from healthcare provider organizations. With only 65 seats available, this highly curated experience offers an intimate environment for decision-makers responsible for leading system-wide artificial intelligence strategies. Held at the Renaissance Boston Seaport District, the Summit functions as a critical executive workshop, blending strategic programming with elevated networking and immersive roundtable exercises. Participants will work alongside peers to align priorities, stress-test roadmaps, share implementation lessons, and refine governance frameworks essential for responsible AI adoption. The experience concludes with a private, culminating executive dinner, providing an additional opportunity for meaningful dialogue, cross-industry connection, and deeper relationship-building among leaders at the forefront of healthcare AI.
Keynote Address
AI at Scale: From 100 Hospitals to Population Precision Health – Dr. Fahad Razak takes the stage to demonstrate what it truly means to operationalize AI at scale. Drawing on his experience co-founding GEMINI (one of the world’s largest hospital research networks), he explores how AI can move beyond pilots to deliver measurable impact across more than 100 hospitals. Dr. Razak will share how data-driven infrastructure, rigorous analytics, and mission-focused leadership can translate into better decisions at both the bedside and the population level. Attendees will gain a clear perspective on how scaling AI responsibly can accelerate the shift toward population precision health, where insights are not only predictive, but actionable across entire health systems.